Pancreatic Cancer Research

ResearcherHegp - Paris - FranceNo recent work listed

Julien Taieb

Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
0
Pancreatic cancer trials
2 (principal investigator on 1)
Pancreatic cancer grants
0
Collaborators
0
Papers, trials and grants by year

2015: 1 trial · 2016: none · 2017: none · 2018: 1 trial

Trials 2

  1. First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI Principal investigator NCT03693677↗
  2. FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine Study chair NCT02827201↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.